Literature DB >> 2247718

Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study.

M D Schluchter1.   

Abstract

A primary outcome variable in longitudinal studies is often the rate of change of a continuous measurement over time. Examples include the one-second forced expiratory volume (FEV1) in pulmonary studies or glomerular filtration rate (GFR) in renal studies. An individual patient's least-squares estimate of slope obtained from a linear regression is an imprecise measure of the true slope for that patient, and correlations involving the estimated slopes will be biased due to this measurement error. This paper presents methods for estimating the true correlation between these imprecise slope estimates, or between slope estimates and other variables measured with error. In addition to providing a simple consistent estimator of the correlation, we show how the maximum likelihood estimate of the correlation coefficient and a 100(1 - alpha) per cent confidence interval can be obtained. An example estimating the correlation between GFR and inverse serum creatinine slopes in patients with chronic renal disease is given.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2247718     DOI: 10.1002/sim.4780091007

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Concurrent life-course trajectories of employment and marijuana-use: exploring interdependence of longitudinal outcomes.

Authors:  Motoaki Hara; David Y C Huang; Robert E Weiss; Yih-Ing Hser
Journal:  J Subst Abuse Treat       Date:  2013-07-26

2.  Low protein diets for non-diabetic adults with chronic kidney disease.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Denis Fouque
Journal:  Cochrane Database Syst Rev       Date:  2018-10-04

3.  Low protein diets for non-diabetic adults with chronic kidney disease.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Denis Fouque
Journal:  Cochrane Database Syst Rev       Date:  2020-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.